Connect with us
AstraZeneca and 13 scientific societies signed a document promoting a multidisciplinary approach to cardio-renal-metabolic diseases. The agreement emphasizes early diagnosis, care coordination, research, awareness, screening, equitable...
Sylentis, part of PharmaMar Group, secured a €21.1M NextGenerationEU grant for its Syoligo project—Spain’s first RNA drug production plant. Located in Getafe, Madrid, it will focus...
Ulisse Biomed, a biotech company in Trieste’s Area Science Park, collaborates with Johns Hopkins University and the Gates Foundation on a malaria project in Cameroon. Its...
Novo Nordisk is licensing United Laboratories’ experimental triple agonist obesity drug, UBT251, for $200M upfront, with potential payments up to $1.8B. This move strengthens its pipeline...
Sofinnova Partners’ Biovelocità II fund raised €165 million, surpassing expectations with support from Amgen, Bristol Myers Squibb, and Pfizer. Expanding across Europe, it backs biotech startups...
Spanish researchers developed a broad-spectrum antiviral from chitosan, a natural compound in crustacean shells. It blocks virus entry and works both before and after infection. Effective...
Cancer is Europe's second leading cause of death, expected to rank first by 2035, yet it receives only 7% of healthcare investment. Cases rose 60% from...
A new study in The Lancet shows annual lenacapavir injections could revolutionize HIV prevention, with up to 100% risk reduction in trials. While effective, challenges include...
AstraZeneca is acquiring Belgian biotech EsoBiotec for up to $1 billion to enhance its cancer therapy portfolio. EsoBiotec's innovative ENaBL platform enables rapid, cost-effective cell therapy...
EmTech Italy 2025, organized by MIT Technology Review Italia and Campus Bio-Medico University of Rome, debuted in Italy, focusing on AI’s impact on healthcare, energy, and...